NFL Clears Philadelphia Eagles in Handling of Jalen Hurts’ Blood Clot Diagnosis
The NFL confirms no disciplinary action against the Philadelphia Eagles regarding Jalen Hurts' medical care following his pulmonary embolism diagnosis.
POLICY WIRE — New York, USA — The Philadelphia Eagles will face no disciplinary measures from the NFL regarding the team’s management of quarterback Jalen Hurts’ recent medical crisis, according to an individual familiar with the league’s internal review.
The source, who spoke on the condition of anonymity due to the private nature of the discussions, confirmed that the league found no fault in how the organization handled the situation. In an official statement released Tuesday, the NFL noted that league officials maintained consistent communication with both the Eagles’ medical staff and specialists at the Cleveland Clinic in London throughout the duration of the quarterback’s treatment.
Dr. Allen Sills, the league’s Chief Medical Officer, coordinates medical support for players in international markets in collaboration with the NFL Players Association, the league stated. The NFL emphasized that player care is administered by club medical personnel working alongside independent physicians.
Hurts, who is currently on injured reserve and expected to remain sidelined for the remainder of the season, was diagnosed with deep vein thrombosis and bilateral pulmonary emboli after a blood clot in his left calf migrated to his lungs. The quarterback is currently undergoing treatment with blood thinners and is prohibited from engaging in football activities until he is cleared from the medication.
The medical issue surfaced after Hurts played in a game against the Jacksonville Jaguars in London on Oct. 11, just three days after he initially reported symptoms to the team’s medical staff. Specialists in London had previously identified the condition as a superficial vein thrombosis in his left calf.
Reporting by Policy-Wire (PW)
